Bill & Melinda Gates Foundation becomes the latest investor in the biotech with $5m.
Synlogic, a biotech spin-out of Boston University and Massachusetts Institute of Technology (MIT), has topped up its series A round by $5m thanks to an investment from the Bill and Melinda Gates Foundation. The funding round total now stands at $34.4m. In July 2014, Atlas Ventures and New Enterprise Associates invested $29.4m.
Synlogic, which based on research by James Collins of Boston and Timothy Lu of MIT, is developing bacteria which can seek out a disease or infection, secrete a…
